NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS NASDAQ) stock market data APIs

$18.0163 0.55(3.1%)
as of June 30, 2025
Try our APIs with free plan!

NewAmsterdam Pharma Company N.V. Ordinary Shares Financial Data Overview

Price chart is built with Anychart

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Prev. Close 18.0163
Open 18.5631
High 18.5809
Low 17.9676
52 wk Range 14.06-27.29
Market Cap 2 033 M
Shares Outstanding 112 M
Revenue 47 140 K
EPS -0.3016
Beta -0.025

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get NewAmsterdam Pharma Company N.V. Ordinary Shares data using free add-ons & libraries


Get NewAmsterdam Pharma Company N.V. Ordinary Shares Fundamental Data

NewAmsterdam Pharma Company N.V. Ordinary Shares Fundamental data includes:

  • Net Revenue: 47 140 K
  • EBITDA: -189 582 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-05-12
  • EPS/Forecast: -0.4364
GET THE PACKAGE

Get NewAmsterdam Pharma Company N.V. Ordinary Shares End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

NewAmsterdam Pharma Company N.V. Ordinary Shares News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat